(Q44011623)

English

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Youdim MB

1

1 reference

Europe PubMed Central

28 November 2017

Tipton KF

2

1 reference

Europe PubMed Central

28 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Parkinsonism and Related Disorders

1 reference

Europe PubMed Central

28 November 2017

8

1 reference

Europe PubMed Central

28 November 2017

4

1 reference

Europe PubMed Central

28 November 2017

247-253

1 reference

Europe PubMed Central

28 November 2017

Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific [3H] beta-phenylethylamine binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism underlying anti-apoptotic activity of a (-)deprenyl-related propargylamine, rasagiline.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Selegiline as initial treatment in de novo parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible mechanism of action of deprenyl in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Deprenyl reduces the death of motoneurons caused by axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct monoamine oxidase A and B populations in primate brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900011-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1353-8020(01)00011-6

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44011623&oldid=2105621504"